GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanexa AB (OSTO:NANEXA) » Definitions » EV-to-Revenue

Nanexa AB (OSTO:NANEXA) EV-to-Revenue : 2.64 (As of May. 26, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Nanexa AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Nanexa AB's enterprise value is kr76.39 Mil. Nanexa AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr28.91 Mil. Therefore, Nanexa AB's EV-to-Revenue for today is 2.64.

The historical rank and industry rank for Nanexa AB's EV-to-Revenue or its related term are showing as below:

OSTO:NANEXA' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.61   Med: 87.92   Max: 612.57
Current: 2.64

During the past 10 years, the highest EV-to-Revenue of Nanexa AB was 612.57. The lowest was 0.61. And the median was 87.92.

OSTO:NANEXA's EV-to-Revenue is ranked worse than
55.47% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.285 vs OSTO:NANEXA: 2.64

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), Nanexa AB's stock price is kr0.902. Nanexa AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.35. Therefore, Nanexa AB's PS Ratio for today is 2.58.


Nanexa AB EV-to-Revenue Historical Data

The historical data trend for Nanexa AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanexa AB EV-to-Revenue Chart

Nanexa AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.00 102.53 42.53 22.91 3.61

Nanexa AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.46 9.30 1.72 3.61 2.05

Competitive Comparison of Nanexa AB's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Nanexa AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanexa AB's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nanexa AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nanexa AB's EV-to-Revenue falls into.



Nanexa AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Nanexa AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=76.389/28.908
=2.64

Nanexa AB's current Enterprise Value is kr76.39 Mil.
Nanexa AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr28.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanexa AB  (OSTO:NANEXA) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Nanexa AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.902/0.35
=2.58

Nanexa AB's share price for today is kr0.902.
Nanexa AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.35.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanexa AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nanexa AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanexa AB (OSTO:NANEXA) Business Description

Traded in Other Exchanges
N/A
Address
Virdings Alle 32B, Uppsala, SWE, 75450
Nanexa AB is a pharmaceutical company developing injectable drug products based on the proprietary and innovative drug delivery system PharmaShell - the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. The company develops its own products and also has collaboration agreements with several pharma companies, among others AstraZeneca.

Nanexa AB (OSTO:NANEXA) Headlines

No Headlines